Filing Details
- Accession Number:
- 0001104659-21-040331
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-23 16:31:54
- Reporting Period:
- 2021-03-19
- Accepted Time:
- 2021-03-23 16:31:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1760542 | Hookipa Pharma Inc. | HOOK | () | XX |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1441261 | Fcpr Vi Capital Sofinnova | C/O Hookipa Pharma Inc., 350 Fifth Avenue, 72Nd Floor, Suite 7240 New York, NY 10118 | No | No | Yes | No | |
1574139 | Sas Partners Sofinnova | C/O Hookipa Pharma Inc., 350 Fifth Avenue, 72Nd Floor, Suite 7240 New York, NY 10118 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-03-19 | 166,230 | $14.60 | 3,739,964 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to a Rule 10b5-1 trading plan dated September 30, 2020 previously adopted by the Reporting Person.
- Sofinnova Partners SAS is the managing company of Sofinnova Capital VI FCPR and disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any.